Introduction
Autoimmune syndromes are often associated with deviations of the lymphocyte repertoires characteristic of physiologic autoreactivity To understand pathogenic processes, it is important to investigate whether such alterations are primary or secondary, and which mechanisms bring them about. It is now established that B and T cell repertoires are continuously selected during life, both along lymphocyte differentiation in bone marrow (BM) and thymus, and at the periphery, by differential persistence and/or expansion of T or B cell clones (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Disease-associated repertoire alterations could thus result from either central or peripheral perturbations in their selection. Recent observations would suggest, however, that central and peripheral B lymphocyte repertoires are intimately related, partly because of specific antibody-dependent 'feedback' regulation of B cell production (13) (14) (15) The pathogenesis of the genetically determined 'lupus-like' syndromes in mice is not established. Introduction of the Ipr mutation in homozygous form onto different genetic backgrounds in mice results in the development of a generalized autoimmune syndrome, bearing clinical similarities with systemic lupus erythematosus in humans (16) (17) (18) . Common B cell features include polyclonal activation, increased serum autoantibody titers and a skewed B cell repertoire (18) (19) (20) (21) . Alterations in the T cell compartment, involving major distortions in populations of thymocytes and peripheral T lymphocytes, on the other hand, are unique to the murine lymphoproliferative {Ipr) syndrome (16, 17, 22) . The Ipr mutation has been localized to the gene encoding Fas (23) , a receptor involved in cell death (24, 25) . Available evidence, however, indicates that Ipr mutant mice appropriately delete differentiating thymocytes (26) (27) (28) (29) (30) In addition, the pathogenic role of the characteristic double-negative T cells in the Ipr syndrome is unclear, while there is evidence for the relevance of B cells and autoantibodies in its pathogenesis (31) (32) (33) (34) . Furthermore, two recent reports analysing the impact of deficient expression of either class I or class 11 MHC molecules on the Ipr phenotype have described the segregation of increased autoantibody production and nephritis from the characteristic high numbers of CD4"CD8~ T cells (35) (36) .
The murine lupoid syndromes do not seem to be associated with a particular haplotype of Ig or TCR gene segments (16, 17, 27) This would imply that the development of abnormal B cell repertoires is related to alterations in the selection of the expressed repertoires, possibly already in differentiating BM lymphocytes. In this paper, we have studied BM B-lineage cells in mice carrying the Ipr defect and report marked deficits in this cellular compartment that seem to be secondary to the autoimmune environment.
Methods

Animals
C57BL76 (B6) mice were obtained from Pasteur Institute or Iffa Credo (Orleans, France) and C57BL/6.Ipr/lpr (B6.lpr) mice were provided by Dr F Loor (Universite Louis Pasteur, Strasbourg, France), maintained in our colony, and used between 4 weeks and 15 months of age.
Flow cytometry
Cell suspensions and flow cytometric analyses were performed as described (13) . Briefly, splenic and bone marrow cell suspensions were incubated in BSS supplemented with 1 % FCS and 0.1% sodium azide on ice, with the following mAb, either coupled with biotin (and revealed with streptavidinphycoerythtin; Becton Dickinson, Mountain View, CA) or dir- Enriched pre-B cells were cultured on cloned stromal cells (S17) and IL-7, supporting pre-B cell growth and differentiation as described (45) (46) (47) . Briefly, S17 cells were cultured at 5X10
4 cells/ml in Opti-MEM (Gibco, Gaithersburg, MD) supplemented with 5% FCS, penicillin, streptomycin (Flow, Irvine, UK) and 5X10" 5 M 2-mercaptoethanol (Merck, Darmstadt, Germany), in 24-well culture plates to confluence. After irradiation (2000 rad), 10 4 to 10 s B220+ IgM" cells/ ml were added to the cultures. Opti-MEM was additionally supplied with recombinant IL-7, obtained from culture supernatants of IL-7-producing transfectants (48), at optimal concentration for pre-B cell growth, as determined in titration experiments. Limiting dilution analyses for determination of the frequency of IL-7 responding pre-B cells were performed in the same culture conditions, using 96-well microtiter plates. Input cell numbers of B220 + lgM~ ranged from 300 to 1 cell/ well in 3-fold dilutions, assessing for growth by microscopy on day 10 of culture (48 cultures at each concentration).
Results
Decreased pre-B and B cell numbers in the BM of B6. Ipr mice
While characterizing BM cell populations in B6./prmice, we observed a marked decrease of B-lineage cells in diseased animals. As shown in Fig. 1 , the BM lymphoid compartment of B6./prmice was selectively reduced as compared with agematched B6 controls. This reduction was due to a selective decrease in the representation of pre-B and B cells, as defined by the surface expression of B220 and IgM, while BM T cells were scored at control levels. As the total numbers of BM cells were comparable in both groups of mice, these results demonstrate a deficit in total numbers of BM B-lineage cells in B6./p/rnice ( Table 1 ) that is not due to BM infiltration by other lymphoid cells. B cells are more severely depleted than pre-B cells, particularly the subpopulation expressing high levels of B220, corresponding to the most mature B cell population in BM (49) .
B-lineage deficiency in B6 Ipr mice was exclusively found in BM Thus, both spleen (Table 1 ) and lymph nodes (data not shown) of the same mice contained normal (in young animals) or augmented numbers of B cells. 
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Age dependence of the BM B-lineage cell depletion in B6.lpr mice
In order to evaluate the severity of BM B-lineage deficits with disease progression, we analysed BM compartments in a series of B6.Ipr mice at different ages, together with agematched controls. As shown in Fig 2, normal B6 mice show an age-dependent decrease in BM pre-B cell representation, which is much less marked for B cells, as previously described (50) . In contrast, B6.Ipr animals, from 2 months onwards, show marked B and pre-B cell deficits By 10 months of age, the representation of B and pre-B cells in the BM of B6.lpr mice is so low that it comes close to detection limits in flow cytometry. Some groups of mice studied for BM B-lineage composition were also examined for clinical parameters of disease development, i.e lymphadenopathy, proteinuria, skin lesions, body weight, total serum Ig concentrations, anti-DNA and rheumatoid factor antibodies, as well as for the sub-set composition and functional activities of peripheral lymphocytes. In this series, the BM B-hneage deficit was detected before any other disease parameter in B6 Ipr mice and its severity correlated with disease progression, as defined by the clinical and immunological assays. It would appear, therefore, that the BM lymphoid composition is a valuable parameter to assess disease activity in B6./prmice. This notion was reinforced by the recovery of a normal pattern of BM lymphoid composition in B6./pr mice treated with pooled normal isologous Ig (IVIg) (15) according to administration schedules currently used in the therapy of certain human autoimmune diseases (51, 52) . As can be seen in Fig 3, the BM B-lineage cell representation in 10-monthold B6.Ipr mice that had received IVIg 6 months before was comparable to normal age-matched controls, while untreated animals showed a profound deficiency in pre-B and B cells. Interestingly, the normalization of BM B-lineage content in IVIg-treated B6.Ipr mice correlated, in all mice examined, with a markedly improved clinical status, as compared with untreated B6 Ipr (see 15 for an extended description of the clinical effects of IVIg in B6.Ipr mice).
BM B-hneage cell defects in B6.lpr mice are not intrinsic to the cell populations affected
The B6.Ipr defect in BM B-lineage cells could represent primary abnormalities in these cell populations, or else be secondary to local or systemic environmental alterations. In order to directly address this question, the proliferative and differentiative capacities of BM pre-B cells from B6.Ipr and control B6 mice were compared. Isolated B220 + slgM" (pre-B) cells were cultured on feeder layers of cloned stromal cells (45) (46) (47) in medium supplemented with recombinant IL-7 (48). In these conditions, pre-B cell growth could be quantitatively assessed both by cell numbers and by limiting dilution analyses of the frequency of cells initiating IL-7-dependent growth, while the rate of differentiation to lgM + B cells could be compared after IL-7 withdrawal (53) Donor mice used in these experiments were 4-6 months of age, at a time when Ipr mice had developed a pronounced in vivo BM B-lineage deficiency (see Fig. 2 ).
As shown in Fig 4, (Fig. 6) , and decay logarithmically as described (53) , while a population of small surface lgM + B cells increases in frequency (Fig. 6 ). The representation of B cells in these cultures upon IL-7 withdrawal was 3-fold lower in B6 Ipr cultures, as compared with B6 ( Fig. 6; day 4) , a consistent finding in three independent experiments, at the various days of assay after IL-7 withdrawal. Figure 7 shows, however, that the actual numbers of newly formed B cells were comparable in both strains, since more cells were recovered in cultures of B6.Ipr pre-B cells and the increased B cell representation after IL-7 withdrawal in these cultures is primarily due to pre-B cell decay. In summary, total numbers of newly formed B cells differentiating from B6 or B6.Ipr pre-B cells at IL-7 withdrawal were comparable, while death of pre-B cells in the absence of IL-7 seemed to be reduced in Ipr BM cultures (Rg. 7)
These observations indicate that there is no detectable intrinsic B6.Ipr B-lineage cell defect, in terms of IL-7-dependent growth or of B cell differentiation from pre-B cells in vitro.
Discussion
The present results demonstrate that (i) early in life (2 months of age), while the BM pre-B cell content of B6./prmice appears quite normal, BM B cell numbers are already significantly diminished, as compared with normal, age-matched controls; (li) the numbers of BM pre-B and B cells in B6.Ipr mice decrease in parallel with the age-dependent development of the autoimmune syndrome in the periphery; (iii) the BM Blineage deficit in B6.Ipr animals was reversed by administration of high doses of normal Ig, that also improved the clinical condition of the mice; (iv) isolated B cell precursors from Decreased rates of pre-B cell production in B6./prmice due to deficient growth-promoting activities in the local environment of B6.Ipr BM were also made unlikely by the finding that irradiated B6 and BQ.Ipr hosts showed comparable competence in supporting the development of transferred B6 BM cells (55) . In summary, it would appear that the B6.Ipr BM deficit is not due to decreased rates of B-lineage cell production. Parenthetically, the increased in vitro survival of B6.Ipr pre-B cells if starved of IL-7 is in line with a general defect in apoptotic mechanisms, imposed by the loss of Fas protein in this strain (23) (24) (25) 56) . On the other hand, there is little evidence for Fas expression in BM B-lineage cells (57) .
Increased rates of pre-B/B cell export from BM could be compatible both with the BM deficit and the peripheral hypercellularity, but no pre-B lymphocytes have been found in the periphery of B6.Ipr mice (data not shown). We are thus left with the possibility that the BM B-lineage deficit in EQ.Ipr mice results from increased (local) elimination A considerable loss of pre-B and B cells in BM of normal mice has been well established (58, 59) , some of which could be due to liganddependent deletion, as suggested both in transgenic models and in normal mice (7, 8, 13, 14, (60) (61) . Most related to our observations, BM B-lineage cell elimination has been shown to result from increasing the concentration of circulating Ig (13) (14) (15) , suggesting that peripheral Ig production could physiologically 'feed back' upon central B lymphopoiesis (62) . In this case, BM B-lineage deficits in B6.Ipr animals could be secondary to the peripheral autoimmune syndrome It should be pointed out that this conclusion is not in opposition to the findings of others (32-34) using different types of chimeric animals, showing that autoantibody production results from an intrinsic defect of IprB cells. Rather, this could suggest that, in autoimmune syndromes, peripheral lymphocyte activities mediate central events in B lymphopoiesis, such as the inhibition of central B cell production by peripheral hyperactivity of B cells, contributing to maintain a pathological 'disease-specific circuit ' Whatever the origin of the BM B-lineage cell deficit in these autoimmune syndromes, it may contribute to the establishment and development of the disease, as a limited BM output will necessarily restrict the range of diversity from which peripheral repertoires are selected. This could lead to continuous selection of peripheral clones and their amplification to pathogenic levels, as demonstrated by Weigert et al. in Ipr mice (19, 20) . Furthermore, if the BM deficit in lupus-like autoimmune syndromes selectively impinges on some V regions, it could restrict the availability of critical clonal reactivities that are necessary in physiology (e.g. 'regulatory' clones) and thus be a fundamental component of pathogenesis.
